JDB153 Combined With Penpulimab for Hepatocellular Carcinoma After Standard Treatment Failure
JDB153 Combined With Penpulimab for Hepatocellular Carcinoma After Standard Treatment Failure
Not yet recruiting · NCT07075419 · Registry updated 2025-07-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JDB153 Combined With Penpulimab for Hepatocellular Carcinoma After Standard Treatment Failure | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Not yet recruiting | Phase 1 / Phase 2 | 2025-07-20 | NCT07075419 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| West China Hospital | 359 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||